Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
- 25 May 2012
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 124 (27) , 6846-6851
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Monodisperse Magnetic Nanoparticles for Theranostic ApplicationsAccounts of Chemical Research, 2011
- The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayersNature Materials, 2011
- Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosisProceedings of the National Academy of Sciences, 2010
- Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of OxaliplatinJournal of the American Chemical Society, 2010
- Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) WarheadsJournal of the American Chemical Society, 2009
- Recent progress in tumor pH targeting nanotechnologyJournal of Controlled Release, 2008
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences, 2008
- Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing DeviceJournal of the American Chemical Society, 2008
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug DesignJournal of the American Chemical Society, 2007